The precursor HS chain is a non-sulfated multimer initially synthesized in Golgi bodies. HS is a linear polysaccharide consisting of a characteristic repeating sequence with repeating disaccharide units (GlcUAβ1-4GlcNAcα1-4)n. The HS is linked to and polymerizes with adjacent serine (Ser) residues in the Ser-Gly dipeptide sequence of the core protein, and hydrophobic amino acids and acidic amino acids at the C-terminus of the Ser-Gly sequence. The fine structure of the HS chain determines its functional properties because the binding of many specific ligands to HS depends on the form of HS modification. HS regulates cell adhesion, proliferation, migration, and differentiation and influences the onset, progression, and outcome of pathophysiological processes such as development, tissue repair, inflammation, infection, and tumorigenesis.
Fig.1 Schematic overview of the function of cell surface HS proteoglycans. (Hayashida, et al., 2022)
Almost all the cells of eukaryotic and multicellular organisms express one or several heparan sulfate proteoglycans (HSPGs) on their cell surface. For the HS-based on the cell surface, we provide the following services:
Fig.2 HS-based cell surface glycoengineering service. (CD BioGlyco)
Paper Title: Changes in heparan sulfate sulfotransferases and cell-surface heparan sulfate during SKM-1 cells granulocytic differentiation and A549 cells epithelial-mesenchymal transition
Technology: Flow cytometry, Gene knock-out, Western blot
Journal: Glycoconjugate Journal
IF: 3.1
Published: 2020
Results: HS 2-O sulfotransferase in mRNA and protein levels were down-regulated during granulocyte differentiation of SKM-1 leukemia cells, and epithelial glucosamine HS 3-O sulfotransferase 3A (HS3ST3A). The cell surface by antibody recognition, was observed in A549 lung cancer cells. In addition, HS3ST3A was negatively correlated with the in vitro cellular metastatic ability of A549 cells, as confirmed by RNA interference techniques, wound healing assays, and in vitro Matrigel invasion assays. In conclusion, specific HS molecules are of interest as molecular drugs and targets for the development and treatment research of cancer diseases.
Fig.3 ATRA-induced granulocytic differentiation of MDS leukemia SKM-1 cells. (Zhao & Wang, 2020)
CD BioGlyco provides several Cell Surface Glycosaminoglycans (GAG) Glycoengineering Service. Moreover, we provide efficient Chondroitin Sulfate (CS), Dermatan Sulfate (DS), Keratan Sulfate (KS), and Hyaluronic Acid (HA) glycoengineering services. We are committed to being your first choice in the field of glycobiology research. If you are interested in our service, please contact us further to introduce the specific service in detail.
References
About Us
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.